Contributor Page
Haug Partners
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 588 0800
Fax: +1 212 588 0500
745 Fifth Avenue, Floor 10
New York
NY 10151
United States
By Richard Kurz, Jessica L. Sblendorio
On June 12, 2017, in a unanimous decision, the Supreme Court of the United States decided Sandoz Inc. v. Amgen Inc., which concerned certain disclosure and notice requirements imposed by the of BPCIA 2009...
By Andrew Wasson, Daniel Worley
The Supreme Court yesterday issued its first opinion interpreting the BPCIA, the statute which created a pathway for the approval of abbreviated applications to market biological products.
By John Dougherty, Jessica L. Sblendorio, Keelan Diana
An arbitral tribunal typically possesses broad powers to set the procedures within an arbitration, including the appointment and management of its own expert to assist the tribunal with technical subjects...
By Jonathan Herstoff, John Balaes
On May 30, 2017, in Impression Products, Inc. v. Lexmark International, Inc.,
By Jonathan Herstoff, Bryan Braunel
In TC Heartland LLC v. Kraft Foods Group Brands LLC, the Supreme Court limited venue in patent suits against domestic corporations to: (1) the corporation's state of incorporation or....
By Richard Kurz, Jessica L. Sblendorio
On May 23, 2017, in NeoChord, Inc. v. University of Maryland, Baltimore and Harpoon Medical, Inc., the Patent Trial and Appeal Board ("PTAB") granted the University's motion to dismiss...
By David Shotlander
For many companies that compete in competitive markets, innovation and product improvement fuels competitive success: create a better product than your competitors, and over time, make it better.
By David Zwally, Michelle Irwin
On January 12, 2017, the Federal Circuit decided Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., providing its first opinion on divided infringement for pharmaceutical method patents under...
By Edgar Haug
Co-Founder and Managing Partner, Ed Haug, spoke to LEADERS Magazine about the firm's expansions of services which include: commercial litigation and strategic counseling; due diligence...
By Richard Kurz, Alexander Callo
On May 1, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. that considered the America Invents Act...
By Richard Kurz, Alexander Callo
In a recent opinion, Mentor Graphics Corp. v. EVE-USA Inc., No. 15-1470 (Fed. Cir. Mar. 16, 2017), the Federal Circuit evaluated when a patentee is entitled to lost profit damages.
By David Shotlander
For many companies that compete in competitive markets, innovation and product improvement fuels competitive success: create a better product than your competitors, and over time, make it better.
By David Zwally, Michelle Irwin
On January 12, 2017, the Federal Circuit decided Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., providing its first opinion on divided infringement for pharmaceutical method patents...
By Edgar Haug, Angus Chen, Jason Lief, Elizabeth Murphy, Andrew Wasson, Michelle Irwin, Jason Kanter, Erika Selli, Camille Turner, Janice Ye
Shire Pharmaceuticals has just achieved another victory in the enforcement of its Lialda® patent.
By Kyle Haug, Nicholas Giove, Laura Chubb, Jonathan Herstoff, Andrew Roper, Damon Lewis, Camille Turner
Following a December 8, 2016 oral argument, the United States Court of Appeals for the Federal Circuit entered a Rule 36 judgment on December 12, 2016...